E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo
about
HCF-1 functions as a coactivator for the zinc finger protein Krox20Signalling in the epidermis: the E2F cell cycle regulatory pathway in epidermal morphogenesis, regeneration and transformationE2F1 in melanoma progression and metastasisThe DP-1 transcription factor is required for keratinocyte growth and epidermal stratificationPro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.ARF differentially modulates apoptosis induced by E2F1 and Myc.Surprising dependency for retinoblastoma protein in ras-mediated tumorigenesisMDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis.Sequence and chromosomal context effects on variegated expression of keratin 5/lacZ constructs in stratified epithelia of transgenic mice.ERK-associated changes in E2F4 phosphorylation, localization and transcriptional activity during mitogenic stimulation in human intestinal epithelial crypt cellsWide-ranging functions of E2F4 in transcriptional activation and repression revealed by genome-wide analysisEmerging roles of E2Fs in cancer: an exit from cell cycle controlConstitutive E2F1 overexpression delays endochondral bone formation by inhibiting chondrocyte differentiation.The role of the E2F transcription factor family in UV-induced apoptosis.The Histone Demethylase PHF8 Is Essential for Endothelial Cell Migration.E2F4 Program Is Predictive of Progression and Intravesical Immunotherapy Efficacy in Bladder CancerIdentification of E2F1 as a positive transcriptional regulator for delta-catenin.Novel functions for the transcription factor E2F4 in development and disease.SWIM: a computational tool to unveiling crucial nodes in complex biological networks.Predicting and preventing melanoma invasiveness: advances in clarifying E2F1 function.PAD2 overexpression in transgenic mice augments malignancy and tumor-associated inflammation in chemically initiated skin tumors.A transcriptionally active pRb-E2F1-P/CAF signaling pathway is central to TGFβ-mediated apoptosis.Human lactoferrin controls the level of retinoblastoma protein and its activity.Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression.E2F modulates keratinocyte squamous differentiation: implications for E2F inhibition in squamous cell carcinoma.A functional role of RB-dependent pathway in the control of quiescence in adult epidermal stem cells revealed by genomic profiling.Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.E2F regulates growth-dependent transcription of genes encoding both catalytic and regulatory subunits of mouse primase.Deregulated expression of DP1 induces epidermal proliferation and enhances skin carcinogenesis.Differences in DNA binding properties between E2F1 and E2F4 specify repression of the Mcl-1 promoter.Myc lacks E2F1's ability to suppress skin carcinogenesis.Role for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosis.Aberrant promoter methylation status is associated with upregulation of the E2F4 gene in breast cancer.pRb2/p130 and p107 control cell growth by multiple strategies and in association with different compartments within the nucleus
P2860
Q24297198-708A9E2A-A3C6-419F-8856-CE9A55805EE1Q24810136-95D8E4F6-093F-4F74-B487-7A94478DC878Q28268420-9BA2E99A-B1A4-4EC5-962F-511BE7197B57Q28512185-3652E302-B34B-4847-959A-629EEFFF714CQ33918198-5F6666E1-EDE0-4AC2-98EA-0E842F88D3D1Q34302211-439DB7ED-F595-497F-BC7A-A35ED2D1F151Q34353737-45ED7636-877F-4C19-AD43-449F05FD19BAQ34489720-3CFA323E-8662-4010-8AF8-88A1D64EF171Q34612585-46CE0A01-D0BF-4D42-8D37-3CEEBFD62447Q34899051-ACDFE743-510F-45BB-8847-2FBB7DD5024BQ34947016-240E0831-13D5-46D8-A2BA-E1AE8562B73FQ35009182-FA41F52E-9D69-43F8-9CC4-2BB0A43E4896Q35148374-6B7DB0A0-71C1-44CB-8E3A-BDE536394BD6Q35669509-984F1998-8853-4405-92BA-AA4BED75E0EEQ35890073-EDF0F7A0-D189-472E-8397-C03C675E8EDCQ36526008-750F3AEF-A263-4637-B8B2-2385FC85D27AQ37038363-5558E136-ED5A-413A-B928-591489A6FC8BQ37524492-54DB54F8-07B1-43F0-B968-BF01AFA4A122Q37710898-23884F81-F0C2-4FA6-BDED-0E024C85E80DQ37809859-59C0811A-C19D-4764-A560-4FCC87ADE85CQ38647603-DBCDA1CD-075A-49AA-A1D4-AEE04BE216BCQ39260980-298CBA49-99E9-4C87-A23B-595B249802A5Q40238940-A40128B5-3EAE-4720-9899-A79D75671A05Q40612848-D363CD9B-EB63-40C1-9B89-841E23E6A456Q40646949-DC4A0394-4BF2-4A57-8CBB-26149A717B49Q41145579-802A7FBC-9D10-42B8-92B0-C5B4A6F6568EQ42276835-51A78D11-BDA3-4651-BAD6-6203DB12DF69Q42498967-B06587ED-2B3E-4BCC-87C6-A9FC1B259830Q42506510-0D87274D-EF99-41AE-9F07-F893C6737719Q42817594-04BE41A8-8360-42E6-B518-543851560963Q43728206-43A3D66E-0BAF-49C2-B539-8CD2BCEACEECQ53959858-68C39653-E0DA-4E29-B0A7-71599DE37AD1Q55211165-A890F532-7E7C-44D6-8E82-9E05C20A30D8Q57007087-014126AB-8925-4126-91D6-21A4EF44F217
P2860
E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo
description
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2000
@ast
im Mai 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2000/05/01)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd op 2000/05/01)
@nl
наукова стаття, опублікована в травні 2000
@uk
مقالة علمية (نشرت في مايو 2000)
@ar
name
E2F4 and E2F1 have similar pro ...... d oncogenic properties in vivo
@ast
E2F4 and E2F1 have similar pro ...... d oncogenic properties in vivo
@en
E2F4 and E2F1 have similar pro ...... d oncogenic properties in vivo
@nl
type
label
E2F4 and E2F1 have similar pro ...... d oncogenic properties in vivo
@ast
E2F4 and E2F1 have similar pro ...... d oncogenic properties in vivo
@en
E2F4 and E2F1 have similar pro ...... d oncogenic properties in vivo
@nl
prefLabel
E2F4 and E2F1 have similar pro ...... d oncogenic properties in vivo
@ast
E2F4 and E2F1 have similar pro ...... d oncogenic properties in vivo
@en
E2F4 and E2F1 have similar pro ...... d oncogenic properties in vivo
@nl
P2860
P921
P1476
E2F4 and E2F1 have similar pro ...... d oncogenic properties in vivo
@en
P2093
P2860
P304
P356
10.1128/MCB.20.10.3417-3424.2000
P407
P577
2000-05-01T00:00:00Z